Read the latest SARC happenings and access our news archive. to our monthly newsletter and receive SARC news and clinical trial updates in your email inbox.

For media inquires and resources, please contact us.

David Kirsch

SARC032 EXPANDED

SU2C has made additional funds available for SARC032 so that we can increase the sample size and power of this randomized, ongoing trial from 102 to 126 evaluable patients. SARC032 …

Read more

Now Recruiting:  CHIEF MEDICAL OFFICER

SARC is seeking a part-time Chief Medical Officer (CMO). The CMO (a newly created role for SARC) will work in partnership with the Chief Executive Officer (CEO) and Chief Scientific …

Read more

SARC 2022 Career Development Award

SARC is pleased to announce our 2022 Career Development Award (CDA) funding opportunity. Past graduates (link here) of the SARC CDA program are pursuing productive independent careers at leading institutions …

Read more

SARC024

Texas Children’s Cancer and Hematology Centers is now open to enrollment in SARC024 (Regorafenib/Refractory Liposarcoma, Osteogenic Sarcoma, Ewing/Ewing-like Sarcomas). SARC024 sites include: • Atrium Health Levine Cancer Institute (Atlanta, GA)• …

Read more
Back to top